V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009708 | 330003637 | null | null | Disease modification (D) | null | 2015-11-28 | Cisplatin 7 day | null | null | 330005530 | CISPLATIN |
| 330009709 | 330003639 | 1.77 | 72 | Curative (C) | null | 2015-01-01 | Trial Unspecified | Y | null | 330005550 | TRIAL |
| 330009710 | 330003642 | 1.66 | 65.2 | Adjuvant (A) | 2017-11-28 | 2018-01-08 | Cisplatin | Y | N | 330005564 | CISPLATIN |
| 330009711 | 330003644 | null | 53 | Palliative (P) | null | 2018-02-11 | EW EuroEwing 2012 Arm B IE | 2 | N | 330005579 | TRIAL |
| 330009712 | 330007960 | 1.69 | 101 | Curative (C) | 2016-02-16 | 2016-03-03 | Trial Unspecified | 02 | N | 330005584 | TRIAL |
| 330009713 | 330003647 | 1.62 | 87 | Neo-adjuvant (N) | 2013-05-27 | 2014-08-30 | DOXORUBICIN | N | N | 330005595 | DOXORUBICIN |
| 330009714 | 330012354 | 1.6 | null | Neo-adjuvant (N) | 2017-06-04 | 2018-02-07 | METHOTREXATE | N | N | 330005613 | METHOTREXATE |
| 330009715 | 330003648 | 1.64 | null | Palliative (P) | 2017-03-30 | 2017-07-31 | Trial Unspecified | 02 | N | 330005616 | TRIAL |
| 330009716 | 330003652 | 1.68 | 59 | Adjuvant (A) | 2016-12-14 | 2017-01-25 | Trial Unspecified | Y | N | 330005625 | TRIAL |
| 330009717 | 330003654 | 0 | 53.7 | Curative (C) | 2017-11-23 | 2017-12-09 | Trial Unspecified | Y | Y | 330005637 | TRIAL |
| 330009718 | 330003655 | 1.53 | 57.75 | Curative (C) | 2016-01-16 | 2016-02-12 | Trial Unspecified | N | Y | 330005649 | TRIAL |
| 330009719 | 330003656 | null | 20.5 | Adjuvant (A) | 2018-03-20 | 2018-05-13 | Cisplatin | null | N | 330005651 | CISPLATIN |
| 330009720 | 330011629 | 1.7 | 74.7 | Curative (C) | 2014-03-28 | 2014-03-30 | EW EuroEwing 2012 Arm B IE | N | N | 330005655 | TRIAL |
| 330009721 | 330003658 | null | 71 | Neo-adjuvant (N) | 2016-09-25 | 2017-03-11 | Trial Unspecified | N | null | 330005676 | TRIAL |
| 330009722 | 330003661 | 1.65 | 45.9 | Neo-adjuvant (N) | 2017-08-03 | 2017-09-21 | Trial Unspecified | N | N | 330005682 | TRIAL |
| 330009723 | 330003670 | 0 | null | Curative (C) | 2015-03-07 | 2016-03-27 | DOXORUBICIN | 2 | N | 330005694 | DOXORUBICIN |
| 330009724 | 330003672 | 1.73 | 82.6 | Neo-adjuvant (N) | 2016-01-18 | 2016-02-18 | Cisplatin 7 day | N | null | 330005698 | CISPLATIN |
| 330009725 | 330003675 | 0 | 82.2 | Adjuvant (A) | null | 2015-02-06 | Trial Unspecified | Y | N | 330005701 | TRIAL |
| 330009726 | 330003676 | 1.77 | 55.5 | null | null | 2017-01-03 | OST Euramos 1 Closed Trial - A | null | null | 330005702 | DOXORUBICIN |
| 330009727 | 330003681 | 0 | null | Adjuvant (A) | 2014-04-15 | 2014-08-27 | MIFAMURTIDE | 1 | N | 330005721 | MIFAMURTIDE |
| 330009728 | 330003682 | 1.77 | null | Curative (C) | null | 2017-08-09 | Cisplatin 7 day | null | null | 330005721 | CISPLATIN |
| 330009729 | 330007985 | 1.66 | null | Curative (C) | 2017-05-31 | 2017-06-13 | Mifamurtide weeks 13-36 | N | N | 330005735 | MIFAMURTIDE |
| 330009730 | 330003689 | 0 | 84.7 | Curative (C) | null | 2014-12-31 | DOXORUBICIN | N | N | 330005748 | DOXORUBICIN |
| 330009731 | 330003690 | null | 58.3 | Curative (C) | 2014-12-23 | 2015-03-21 | Mifamurtide weeks 1-12 | N | N | 330005768 | MIFAMURTIDE |
| 330009732 | 330003692 | 1.72 | null | Palliative (P) | null | 2014-01-16 | Cisplatin 7 day | Y | null | 330005822 | CISPLATIN |
| 330009733 | 330013011 | 1.82 | 99.8 | Curative (C) | 2015-06-13 | 2015-06-13 | Mifamurtide weeks 1-12 | N | N | 330005860 | MIFAMURTIDE |
| 330009734 | 330003694 | 1.61 | 61.2 | Curative (C) | 2015-11-14 | 2015-12-20 | Trial Unspecified | null | null | 330005861 | TRIAL |
| 330009735 | 330003698 | 1.93 | 73.5 | Neo-adjuvant (N) | 2015-10-02 | 2015-10-09 | MIFAMURTIDE | Y | Y | 330005868 | MIFAMURTIDE |
| 330009736 | 330003701 | 0 | 73.3 | Curative (C) | 2011-12-18 | 2013-08-26 | DOXORUBICIN | 02 | N | 330005882 | DOXORUBICIN |
| 330009737 | 330003703 | 1.78 | 87 | Neo-adjuvant (N) | 2016-12-21 | 2016-12-28 | OST Mifamurtide | N | Y | 330005885 | MIFAMURTIDE |
| 330009738 | 330003704 | 0 | 70.4 | Palliative (P) | 2016-10-03 | 2016-10-03 | Trial Unspecified | N | N | 330005891 | TRIAL |
| 330009739 | 330003706 | null | 94 | Adjuvant (A) | null | 2015-10-17 | Mifamurtide weeks 13-36 | Y | null | 330005903 | MIFAMURTIDE |
| 330009740 | 330003707 | 0 | 70.8 | Adjuvant (A) | 2018-10-23 | 2018-10-24 | Trial Unspecified | N | N | 330005922 | TRIAL |
| 330009741 | 330010340 | 1.8 | 80.7 | Curative (C) | 2016-09-09 | 2016-09-09 | DOXORUBICIN | N | N | 330005925 | DOXORUBICIN |
| 330009742 | 330003711 | 1.65 | 57.75 | Curative (C) | 2013-06-11 | 2013-11-21 | DOXORUBICIN | N | N | 330005930 | DOXORUBICIN |
| 330009745 | 330003717 | 1.8 | 70.8 | Curative (C) | 2015-11-04 | 2015-11-06 | OST Euramos 1 Closed Trial - A | N | N | 330005948 | DOXORUBICIN |
| 330009746 | 330003720 | 1.79 | 57 | Neo-adjuvant (N) | 2015-05-16 | 2016-06-23 | METHOTREXATE | Y | N | 330005950 | METHOTREXATE |
| 330009747 | 330003720 | 0 | 55 | Palliative (P) | 2014-10-08 | 2014-10-15 | EW EuroEwing 2012 Arm A VAI | 2 | N | 330005950 | TRIAL |
| 330009748 | 330003720 | 1.64 | 54 | Curative (C) | 2017-01-24 | 2017-04-18 | Cisplatin | N | Y | 330005950 | CISPLATIN |
| 330009750 | 330013332 | 1.79 | 62 | Curative (C) | 2013-01-18 | 2013-11-05 | OST Euramos 1 Closed Trial - A | N | N | 330005981 | DOXORUBICIN |
| 330009751 | 330003721 | 0 | 52.35 | Curative (C) | 2014-09-13 | 2014-10-29 | METHOTREXATE | Y | N | 330005985 | METHOTREXATE |
| 330009754 | 330003727 | 1.61 | 61.1 | Adjuvant (A) | 2015-01-04 | 2015-01-16 | MIFAMURTIDE | 02 | Y | 330006006 | MIFAMURTIDE |
| 330009755 | 330003728 | 1.76 | 62 | Curative (C) | 2017-02-21 | 2017-02-21 | Trial Unspecified | 1 | N | 330006006 | TRIAL |
| 330009756 | 330003729 | 1.51 | 40.6 | Curative (C) | 2014-02-12 | 2014-08-27 | MIFAMURTIDE | N | N | 330006015 | MIFAMURTIDE |
| 330009757 | 330003731 | 1.02 | 74.2 | Neo-adjuvant (N) | 2015-10-05 | 2015-10-08 | EW EuroEwing 2012 Arm B IE | N | N | 330006016 | TRIAL |
| 330009758 | 330008012 | 1.7 | 86 | null | 2017-09-21 | 2017-09-23 | DOXORUBICIN | N | Y | 330006023 | DOXORUBICIN |
| 330009759 | 330003739 | 1.58 | null | Curative (C) | 2013-04-26 | 2013-08-28 | METHOTREXATE | 01 | N | 330006058 | METHOTREXATE |
| 330009761 | 330008019 | 1.66 | 61.2 | Curative (C) | 2014-03-18 | 2014-03-18 | DOXORUBICIN | 2 | N | 330006497 | DOXORUBICIN |
| 330009762 | 330003748 | 0.89 | null | Neo-adjuvant (N) | 2014-05-16 | 2014-06-15 | EW EuroEwing 2012 Arm A VAI | 02 | Y | 330006633 | TRIAL |
| 330009763 | 330003749 | 1.62 | 31 | Curative (C) | 2014-08-27 | 2014-08-28 | DOXORUBICIN | 02 | N | 330006926 | DOXORUBICIN |